News Google promises new AI models for drug discovery Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month.
News Insilico raises $110m for AI-designed drug pipeline Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations.
News Scientific 'superintelligence' firm Lila launches with $200m Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.
News Owkin launches ATLANTIS patient data mining project Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology.
News Ex-DeepMind scientist launches drug discovery company Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.
News Industry steps up as EU debates an action plan for AI Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.
News MSD licenses Lp(a) heart drug from Hengrui in $2bn deal MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
